Ex Parte Nair et al - Page 5


               Appeal No. 2006-1163                                                                                                 
               Application 09/761,143                                                                                               

               preparation of “cyanidin” in the written description in appellants’ specification is with respect to                 
               hydrolysis of anthocyanins, either in a reaction vessel or in vivo, and “aglycon cyanidin” was                       
               tested in specification Example 4.                                                                                   
                       The unqualified term “cyanidin” appears in appealed claims 1 and 15, and on this record                      
               refers to both cyanidin per se and aglycon cyanidin.  The issues thus raised by appellants in the                    
               reply brief, relying on Dekazos, are whether one skilled in this art armed with the knowledge of                     
               the use of the terms cyanidin per se, aglycone cyanidin, aglycon cyanidin and cyanidin aglycone,                     
               and of Dekazos, in considering the disclosure in the written description in the specification                        
               would have recognized that cyanidin per se would have been present in the mixtures of                                
               anthocyanins, bioflavonoids and phenolics prepared from Balaton and Montmorency cherries                             
               following the protocol disclosed at specification FIG. 5 and specification Examples 1 and 2;                         
               that the mixtures of specification Examples 1 and 2 tested in specification Example 6 contained                      
               containing cyanidin per se;  that mixtures of anthocyanins 1-3 of specification FIG. 1 tested in                     
               specification Example 4 contained cyanidin per se;  and that cyanidin per se was separated from                      
               such mixtures.                                                                                                       
                       The record shows that the examiner considered and entered the reply brief and thus                           
               Dekazos, which in any event, is in the record as set forth in the specification as filed.  We find no                
               form in the official electronic files of the USPTO indicating that Dekazos was officially made of                    
               record as considered by the examiner.                                                                                
                       Accordingly, the examiner is required to take appropriate action consistent with current                     
               examining practice and procedure to enter Dekazos into the record and to consider the issues                         
               raised by appellants relying on this reference in the reply brief as we have stated these issues                     
               above, in light of our finding and discussion above of the written description in the specification                  
               and the meaning of the terms used therein, with a view toward placing this application in                            
               condition for decision on appeal with respect to the issues presented.                                               
                       This remand is made for the purpose of directing the examiner to further consider the                        
               grounds of rejection.  Accordingly, if the examiner submits a supplemental answer to the Board                       
               in response to this remand, “appellants must within two months from the date of the                                  
               supplemental examiner’s answer exercise one of” the two options set forth in 37 CFR                                  


                                                               - 5 -                                                                



Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007